Brief: Cns Pharmaceuticals Says Current Expectation Is That Cash On Hand, Is Sufficient To Fund Operations Beyond Interim Analysis And Into Q4 Of 2023

CNS Pharmaceuticals

15/05/2023 13:43

May 15 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS - CURRENT EXPECTATION IS THAT CASH ON
HAND,
IS SUFFICIENT TO FUND OPERATIONS BEYOND INTERIM ANALYSIS AND
INTO Q4 OF 2023
    * CNS PHARMACEUTICALS - NET LOSS FOR QUARTER WAS ABOUT $4.9
MILLION VERSUS ABOUT $3.2 MILLION

Source text for Eikon:  ID: 
Further company coverage:  CNSP.O 

 ((Reuters.Brief@thomsonreuters.com;))